Kiyoshi Fujinami

1.6k total citations
45 papers, 1.2k citations indexed

About

Kiyoshi Fujinami is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Kiyoshi Fujinami has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 12 papers in Surgery. Recurrent topics in Kiyoshi Fujinami's work include Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Cancer-related Molecular Pathways (4 papers). Kiyoshi Fujinami is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (8 papers) and Cancer-related Molecular Pathways (4 papers). Kiyoshi Fujinami collaborates with scholars based in Japan, United States and United Kingdom. Kiyoshi Fujinami's co-authors include Yoshinobu Kubota, Hiroji Uemura, Yasuhide Miyoshi, Hitoshi Ishiguro, Hiroji Uemura, Noboru Nakaigawa, Hiroshi Miyamoto, Masaoki Harada, Masahiko Hosaka and Hitoshi Kitamura and has published in prestigious journals such as The Journal of Urology, International Journal of Cancer and Modern Pathology.

In The Last Decade

Kiyoshi Fujinami

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiyoshi Fujinami Japan 19 549 442 245 218 208 45 1.2k
Hiroyuki Kaneto Japan 15 589 1.1× 303 0.7× 261 1.1× 158 0.7× 104 0.5× 47 1.4k
Anne-Marie Préaux France 19 439 0.8× 121 0.3× 182 0.7× 170 0.8× 106 0.5× 34 1.4k
Xianli He China 22 847 1.5× 169 0.4× 291 1.2× 150 0.7× 552 2.7× 68 1.5k
Yasuji Yoshikawa Japan 17 522 1.0× 260 0.6× 330 1.3× 85 0.4× 125 0.6× 51 1.1k
Myoung Jae Kang South Korea 23 768 1.4× 449 1.0× 684 2.8× 75 0.3× 312 1.5× 60 1.9k
Eugene Trogan United States 9 761 1.4× 127 0.3× 279 1.1× 67 0.3× 299 1.4× 9 2.1k
Smadar Avigad Israel 25 669 1.2× 349 0.8× 251 1.0× 127 0.6× 235 1.1× 67 1.4k
Yoshihiko Tokusashi Japan 19 294 0.5× 159 0.4× 391 1.6× 81 0.4× 163 0.8× 58 1.5k
Sakari Kakko Finland 17 366 0.7× 145 0.3× 69 0.3× 45 0.2× 114 0.5× 36 891
Xiaoyan Bai China 19 605 1.1× 316 0.7× 292 1.2× 36 0.2× 399 1.9× 55 1.2k

Countries citing papers authored by Kiyoshi Fujinami

Since Specialization
Citations

This map shows the geographic impact of Kiyoshi Fujinami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoshi Fujinami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoshi Fujinami more than expected).

Fields of papers citing papers by Kiyoshi Fujinami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyoshi Fujinami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoshi Fujinami. The network helps show where Kiyoshi Fujinami may publish in the future.

Co-authorship network of co-authors of Kiyoshi Fujinami

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoshi Fujinami. A scholar is included among the top collaborators of Kiyoshi Fujinami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoshi Fujinami. Kiyoshi Fujinami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miyoshi, Yasuhide, Kazumi Noguchi, Masataka Taguri, et al.. (2015). Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer. BMC Cancer. 15(1). 338–338. 28 indexed citations
2.
Uemura, Hiroji, Kiyoshi Fujinami, Akira Iwasaki, et al.. (2012). Possible anti-tumor activity of initial treatment with zoledronic acid with hormonal therapy for bone-metastatic prostate cancer in multicenter clinical trial. International Journal of Clinical Oncology. 18(3). 472–477. 11 indexed citations
3.
Matsumoto, Tatsuya, et al.. (2010). [Rupture of renal angiomyolipoma during pregnancy: a case report].. PubMed. 56(5). 261–4. 4 indexed citations
4.
Ohta, Shinsuke, Hiroji Uemura, Yoshiro Matsui, et al.. (2008). Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 107(1). 81–91. 53 indexed citations
5.
Noguchi, Kazumi, Hiroji Uemura, Jun‐ichi Teranishi, et al.. (2006). A QUESTIONNAIRE ON SUITABLENESS AND ACCEPTABLENESS OF CANCER NOTIFICATION IN AGED JAPANESE PROSTATE CANCER PATIENTS. The Japanese Journal of Urology. 97(1). 48–56. 1 indexed citations
6.
Hasumi, Hisashi, Hitoshi Ishiguro, Masashi Nakamura, et al.. (2005). Neuroserpin (PI‐12) is upregulated in high‐grade prostate cancer and is associated with survival. International Journal of Cancer. 115(6). 911–916. 20 indexed citations
7.
8.
Ishiguro, Hitoshi, Noboru Nakaigawa, Yasuhide Miyoshi, et al.. (2005). Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. The Prostate. 64(1). 92–100. 179 indexed citations
9.
Uemura, Hiroji, et al.. (2005). USEFULNESS OF EXTENSION OF DISEASE AS A PROGNOSTIC FACTOR IN RELAPSED PROSTATE CANCER PATIENTS OF STAGE D. The Japanese Journal of Urology. 96(3). 442–447. 1 indexed citations
10.
Miura, Takeshi, et al.. (2004). A CASE OF WELL CONTROLLED RENAL SMALL CELL CARCINOMA WITH METASTASIS TREATED BY INTENSIVE THERAPY. The Japanese Journal of Urology. 95(4). 679–683. 2 indexed citations
11.
Miyoshi, Yasuhide, Hitoshi Ishiguro, Hiroji Uemura, et al.. (2003). Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer. The Prostate. 56(4). 280–286. 43 indexed citations
12.
Miyoshi, Yasuhide, et al.. (2001). Fluorescence in situ hybridization evaluation of c-erbB-2 gene amplification and chromosomal anomalies in bladder cancer.. PubMed. 7(8). 2463–7. 36 indexed citations
13.
Miyoshi, Yasuhide, Hiroji Uemura, Kiyoshi Fujinami, et al.. (2000). Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients. The Prostate. 43(3). 225–232. 58 indexed citations
14.
Fujinami, Kiyoshi, et al.. (1999). [A case of advanced retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide].. PubMed. 45(7). 463–6. 2 indexed citations
15.
Uemura, Hiroji, et al.. (1997). Telomerase Activity in Primary Prostate Cancer. The Journal of Urology. 1161–1165. 12 indexed citations
16.
Fujinami, Kiyoshi, et al.. (1996). [Combination therapy with 5-fluorouracil (5-FU), cisplatin (CDDP) and interferon alpha-2B (IFN alpha-2B) for advanced renal cell carcinoma].. PubMed. 23(12). 1689–91. 1 indexed citations
17.
Matsuzaki, Junichi, Hiroshi Miyamoto, Ichiro Ikeda, et al.. (1996). DNA polymerase β gene mutations in human bladder cancer. Molecular Carcinogenesis. 15(1). 38–43. 32 indexed citations
18.
Kubota, Yoshinobu, Kiyoshi Fujinami, Hiroji Uemura, et al.. (1995). Retinoblastoma gene mutations in primary human prostate cancer. The Prostate. 27(6). 314–320. 78 indexed citations
19.
Fujinami, Kiyoshi, et al.. (1995). COMPARISONS OF HISTOLOGICAL GRADING BETWEEN BIOPSY AND RADICAL PROSTATECTOMY SPECIMENS IN PROSTATIC ADENOCARCINOMA. The Japanese Journal of Urology. 86(9). 1460–1465. 1 indexed citations
20.
Kubota, Yoshinobu, Taro Shuin, Hiroji Uemura, et al.. (1995). Tumor suppressor gene P53 mutations in human prostate cancer. The Prostate. 27(1). 18–24. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroyuki Kaneto Breakdown of academic impact, for papers by Anne-Marie Préaux Breakdown of academic impact, for papers by Xianli He Breakdown of academic impact, for papers by Yasuji Yoshikawa Breakdown of academic impact, for papers by Myoung Jae Kang Breakdown of academic impact, for papers by Eugene Trogan Breakdown of academic impact, for papers by Smadar Avigad Breakdown of academic impact, for papers by Yoshihiko Tokusashi Breakdown of academic impact, for papers by Sakari Kakko Breakdown of academic impact, for papers by Xiaoyan Bai
Rankless by CCL
2026